1. Home
  2. PBH vs NUVB Comparison

PBH vs NUVB Comparison

Compare PBH & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$62.05

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$9.47

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBH
NUVB
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
PBH
NUVB
Price
$62.05
$9.47
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$86.40
$10.63
AVG Volume (30 Days)
500.4K
6.8M
Earning Date
02-05-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.04
N/A
Revenue
$1,110,479,000.00
$26,748,000.00
Revenue This Year
N/A
$609.55
Revenue Next Year
$2.50
$197.91
P/E Ratio
$15.27
N/A
Revenue Growth
N/A
1137.19
52 Week Low
$57.25
$1.54
52 Week High
$90.04
$9.53

Technical Indicators

Market Signals
Indicator
PBH
NUVB
Relative Strength Index (RSI) 57.98 74.81
Support Level $60.98 $8.13
Resistance Level $62.92 $8.95
Average True Range (ATR) 1.45 0.54
MACD 0.28 -0.01
Stochastic Oscillator 79.70 96.87

Price Performance

Historical Comparison
PBH
NUVB

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: